Drug Discovery World

NOVEMBER 27, 2023

With more than 20 years of experience in business management, strategy, marketing, and product management, Anis also has research background from biotech, pharmaceutical, and premier academic organisations. [link] About the author Anis is within the strategy group in Life Sciences at Revvity, Inc.

Production 147

Production Engineering Molecular Biology Drug Development 147

Drug Target Review

MARCH 15, 2024

Disclaimer: For research use only. With more than 20 years of experience in business management, strategy, marketing and product management, Anis also has a research background in biotech, pharmaceutical and premier academic organisations.

Engineering 105

Engineering Molecular Biology Protein Expression Medical Schools 105

Broad Institute

AUGUST 2, 2023

Daniel Hochbaum Daniel Hochbaum Daniel Hochbaum, Harvard Medical School Daniel Hochbaum, Ph.D. Ralph Lawton, Harvard Medical School Ralph Lawton is currently under Dr. Hochbaum’s mentorship and will complete his MD/Ph.D. Helsinki Center of Economic Research, Helsinki 2013). earned his Ph.D.

Medical Schools 52

Medical Schools Doctors International Science 52

Drug Target Review

DECEMBER 28, 2023

Using powerful bioinformatics technology developed and validated with sequence data from the TRACERx study, researchers are able to identify clonal neoantigens from a patient’s unique tumour profile. Researchers believe supplementing bioinformatics with artificial intelligence trained on real-world data will provide the answer.

Bioinformatics 105

Bioinformatics Immune Response DNA Vaccine 105

The Pharma Data

NOVEMBER 30, 2020

Doctors already learn the technique in medical school, noted Dr. Scott Isaacs, spokesman for the American Association of Clinical Endocrinology and medical director for Atlanta Endocrine Associates. Agency for Healthcare Research and Quality. So why don’t more doctors use this approach?

Doctors 52

Doctors Medical Schools Hospitals Disease 52

The Pharma Data

JANUARY 20, 2021

Department of Veterans Affairs (VA) hospitals, researchers found a pattern: COVID-19 patients were nearly twice as likely to die during periods when ICUs were dealing with a surge of patients with the illness. Luis Ostrosky, a professor of infectious diseases at McGovern Medical School at UTHealth in Houston. WEDNESDAY, Jan.

Medical Schools 52

Medical Schools Hospitals Doctors Disease 52

Drug Target Review

FEBRUARY 26, 2024

Alani currently serves as the Herbert Mescon Endowed Professor and Chair of Dermatology at Boston University Chobanian & Avedisan School of Medicine and the Dermatologist-in-Chief at Boston Medical Center, a position she has held since January, 2010. degree with Honors and Distinction in Research from the University of Michigan.

Therapies 59

Therapies Molecular Biology Regulations Medical Schools 59

The Pharma Data

DECEMBER 28, 2020

Experts said the findings give more support to something that’s been advocated, but not commonly done by doctors and nurses: Checking patients’ blood pressure in both arms. Instead, he explained, doctors can consider between-arm differences one “marker” of a patient’s heart disease risk. And then what?

Doctors 52

Doctors Medical Schools Nurses Disease 52

The Pharma Data

MAY 16, 2021

Scientific Research includes studies from from The University of East Anglia, England, Harvard Medical School, the Cell journal , and the Environmental Working Group. The content of this site is for informational purposes only, and is not intended to replace professional medical advice, diagnosis or treatment.

Medical Schools 52

Medical Schools Production Doctors Treatment 52

The Pharma Data

JANUARY 20, 2021

Department of Veterans Affairs (VA) hospitals, researchers found a pattern: COVID-19 patients were nearly twice as likely to die during periods when ICUs were dealing with a surge of patients with the illness. Luis Ostrosky, a professor of infectious diseases at McGovern Medical School at UTHealth in Houston. WEDNESDAY, Jan.

Medical Schools 40

Medical Schools Hospitals Doctors Disease 40

The Pharma Data

JANUARY 11, 2021

Dr. Luis Ostrosky, a professor of infectious diseases at McGovern Medical School at UTHealth in Houston, is among the doctors seeing long haulers. ” In the new study, a large proportion of patients with mild COVID-19 still felt unwell when they saw their doctor over two months later.

Doctors 52

Doctors Hospitals Medical Schools Disease 52

Drug Target Review

FEBRUARY 29, 2024

Through further research and work as a principal investigator on clinical studies for several central nervous system indications, I laid the groundwork for a career in gene therapy drug development. Deep dedication is required to advance patient care, conduct clinical studies, and pursue bench-based research.

Therapies 111

Therapies Disease Clinical Trials Science 111

The Pharma Data

DECEMBER 29, 2020

These new cancers can result from a genetic predisposition, from treatments such as radiation and chemotherapy used to fight the first cancer, as well as from unhealthy lifestyles such as smoking and obesity, according to researchers from the American Cancer Society. million Americans who beat cancer between 1992 and 2017.

Medical Schools 52

Medical Schools Doctors Treatment Research 52

The Pharma Data

DECEMBER 18, 2020

Researchers at the University of Michigan Hospital found that in cases where Black patients appeared to have adequate oxygen levels on pulse oximetry, their blood oxygen was actually low 12% of the time. In contrast, the mismatch happened in white patients less than 4% of the time, the researchers report in the Dec. © 2020 HealthDay.

Hospitals 52

Hospitals Medical Schools International Doctors 52

NIH Director's Blog: Drug Development

APRIL 2, 2020

After confirmation by further research, these maps may well provide a basis for the design and development of therapeutics that specifically target this critical interaction. This is of particular concern to doctors whose patients are already taking the medications to control hypertension. The team, led by Scott D.

Drug Development 52

Drug Development Drugs Medical Schools Science 52

The Pharma Data

JANUARY 27, 2021

Researchers found that a three-month cardiac rehabilitation program improved fitness levels and muscle strength in 24 stroke survivors. While the study was small, the researchers said it offers evidence of what’s intuitive: People recovering from a stroke benefit from regular, structured exercise. WEDNESDAY, Jan. Source link.

Medical Schools 52

Medical Schools Hospitals Therapies Doctors 52

The Pharma Data

MAY 14, 2021

Description: In this 8 Episode Diabetes-Fighting Series, I get to meet several doctors, nutritionists, current and former diabetics, from the around the world. As you read the book you will learn the signs and symptoms, the complications, and how a doctor diagnoses and monitors and treats patients with type 2 diabetes.

Doctors 52

Doctors Production Medical Schools Pharma Companies 52

Broad Institute

JUNE 1, 2023

Researchers at the Broad Institute of MIT and Harvard are beginning to uncover genetic factors contributing to gestational hypertension and preeclampsia, two common HDPs. The scores could help doctors identify and treat at-risk individuals earlier in pregnancy with existing but underutilized strategies such as low-dose aspirin.

Doctors 133

Doctors Medical Schools Hospitals DNA 133

Broad Institute

JANUARY 30, 2024

Patients with possible undiagnosed infections kept him up at night as he ran through their medical histories, occupations, and personal life details in his mind, searching for clues to the identity of the microscopic invaders.

Hospitals 137

Hospitals Medical Schools Virus Science 137

Broad Institute

MAY 30, 2023

#WhyIScience Q&A: A process development lead returns to her research roots By Corie Lok May 30, 2023 Breadcrumb Home #WhyIScience Q&A: A process development lead returns to her research roots Isabella Teixeira-Soldano reflects on her time as a technician in Broad’s COVID-19 testing lab and how that led to a position doing single-cell research.

Research 89

Research Medical Schools Doctors Science 89

The Pharma Data

DECEMBER 2, 2020

Female Doctors Less Likely to Be Promoted to Upper Faculty Ranks. 2, 2020 — Women physicians in academic medical centers are less likely than men to be promoted to upper faculty ranks, according to a study published in the Nov. medical schools. Professional. WEDNESDAY, Dec. Richter, Ph.D., Richter, Ph.D.,

Doctors 52

Doctors Medical Schools Research 52

Alta Sciences

MARCH 27, 2024

As if that isn’t enough, she is also working toward her PhD, with research focusing on the impact of supramental awareness on disease prevention, healing, and health. Get to know Eryn with this Q&A: What motivated you to pursue a doctorate degree? Not really, although I contemplated medical school for a while.

Drug Development 52

Drug Development Medical Schools Pharma Companies Drugs 52

Broad Institute

JULY 10, 2023

Thanks in part to her research, more geneticists are now studying a wider diversity of people and accounting for genetic ancestry in their analyses. Through this work, Martin is showing how a methodical, data-driven kind of social justice can help improve equity in scientific research and lead to better science.

Bioinformatics 98

Bioinformatics Disease Medical Schools Research 98

Broad Institute

JUNE 21, 2023

To assess Lipocyte Profiler, the researchers analyzed white and brown fat cells and liver cells, focusing on traits such as the size, the number, and the location of lipid droplets in a cell. The researchers also looked at the tool’s ability to detect changes in cell morphology after exposure to drugs and small molecule compounds.

Small Molecule 52

Small Molecule Cell Based Assays Medical Schools Disease 52

Broad Institute

DECEMBER 6, 2023

A new, large-scale reference created by researchers at the Broad Institute of MIT and Harvard could help scientists and clinicians better understand the role of cytokines in health and disease. AC: This research could have far-reaching implications, accelerating our understanding of natural immune responses and human immune-related diseases.

Immune Response 138

Immune Response RNA Medical Schools Disease 138

The Pharma Data

NOVEMBER 16, 2020

The “polypill” containing three generic blood pressure medications and a statin dramatically reduced the risk of heart-related illness in people with no prior history of heart problems, according to clinical trial results. The polypill/aspirin combination reduced heart problems and deaths by 31%, the researchers discovered.

Health Insurance Companies 52

Health Insurance Companies Doctors Medical Schools Pharma Companies 52

Broad Institute

MAY 2, 2024

Tell us a bit about your research. In undergrad, I thought about going to medical school, but I didn’t want to work in a hospital. You can do a lot these days outside of the hospital and still really feel like you’re on the front lines and the cutting edge of research and be able to work on interesting problems.

Science 124

Science Medical Schools Hospitals Disease 124

The Pharma Data

MAY 15, 2021

And I know I went to Harvard Medical School, not Harvard Business…. As always, if you currently have a medical condition or are taking medication, I advise showing a bottle to your doctor before taking it. Featuring research from Obesity Society Journal and the Medical Science Monitor.

Production 52

Production Packaging Medical Schools Science 52

The Pharma Data

DECEMBER 3, 2020

December 5, 2:00 PM – 3:30 PM; Platform A: Translational Research / Genetics. Translational Research / 2B. December 8, 1:30 PM – 4:00 PM; Annual Fundamentals Symposium: Fundamentally New Ideas in Epilepsy Treatment and Research. No investigational medications or other treatments will be provided. Lori Isom, Ph.D.,

Protein Expression 52

Protein Expression Clinical Trials Pharmacokinetics Trials 52

The Pharma Data

DECEMBER 22, 2020

is so sporadic,” Jeremy Luban, a virologist at the University of Massachusetts Medical School, told the Post. The federal government invested in the research and development of the vaccine and bought 200 million doses in advance, bringing the government outlay to $4.1 . “It may very well be here.

Packaging 52

Packaging Vaccine Government Hospitals 52

Drug & Device Law

DECEMBER 29, 2023

These opinions in search of a rationale (one expert had a prior contrary publication) did not become admissible via cherry-picking among research concerning multiple different diagnoses; that was “not generally accepted.” In light of all the other research that had followed, the M.D. Same result – no causation. Zydus Pharms USA, Inc.

Testimonials 105

Testimonials FDA Drugs Vaccine 105